Polianta Ltd’s Amedisys AMED Stock Holding History

Polianta Ltd’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,600	Closed	-$1.11M	–	66
2020 Q2	$1.11M	Buy	+5,600	New	+$1.04M	0.72%	12
2019 Q2	–	Sell	-14,400	Closed	-$1.77M	–	70
2019 Q1	$1.77M	Buy	+14,400	New	+$1.81M	0.66%	26

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polianta Ltd's AMED Position: Q3 2020 in Review

Polianta Ltd sold out of Amedisys (AMED) in Q3 2020, closing a stake of 5,600 shares — an estimated $1.11M sold.

Polianta Ltd first reported a position in AMED in Q1 2019 and held it in 2 quarters. The position peaked at $1.77M in Q1 2019. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

Polianta Ltd reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
Polianta Ltd sold 5,600 Amedisys shares in Q3 2020, an estimated $1.11M.
Polianta Ltd first reported a position in Amedisys in Q1 2019 and held it in 2 quarters.
Polianta Ltd's Amedisys position peaked at $1.77M in Q1 2019.
397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Polianta Ltd's 13F filing for Q3 2020, filed 7 Oct 2020.